4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-009932
Options or other derivatives
- Chief Commercial Officer acquired 4,466,376 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Piccina Cintia Chief Commercial Officer | 2022-01-31 | Grant or award · Option to purchase Ordinary Shares | +3,376,992 | 3,376,992 | D | ||
| Piccina Cintia Chief Commercial Officer | 2022-01-31 | Grant or award · Option to purchase Ordinary Shares | +754,200 | 754,200 | D | ||
| Piccina Cintia Chief Commercial Officer | 2022-01-31 | Grant or award · Option to purchase Ordinary Shares | +335,184 | 335,184 | D | ||
Loading xslF345X03/tm221700-20_4seq1.xml…